Literature DB >> 7579080

Cholesterol emboli presenting as acute allograft dysfunction after renal transplantation.

I Singh1, P D Killen, A B Leichtman.   

Abstract

Cholesterol emboli are a common complication of atherosclerotic vascular disease. A 40-yr-old renal transplant recipient who developed acute allograft dysfunction 1 day after the initiation of cyclosporine therapy and 6 days after transplantation is described. A renal allograft biopsy revealed cholesterol emboli in interlobular arteries and in glomeruli. Four previously reported cases of cholesterol emboli in renal allografts are described, and the cause and pathogenesis of atheroembolic disease are reviewed. Atheroemboli causing injury to the renal allograft may arise from either donor or recipient vessels. Vigilance for the occurrence of these emboli needs to be maintained when donor or recipient vessels demonstrate evidence of significant atherosclerotic vascular disease.

Entities:  

Mesh:

Year:  1995        PMID: 7579080     DOI: 10.1681/ASN.V62165

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  3 in total

Review 1.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

2.  Cholesterol Embolization Syndrome After Kidney Transplantation: A Case Series and Systematic Review.

Authors:  Marith I Francke; Marian C Clahsen-van Groningen; Thierry P P van den Bosch; Jan U Becker; Dennis A Hesselink
Journal:  Transplant Direct       Date:  2021-06-18

3.  Cholesterol-crystal embolism presenting with delayed graft function and impaired long-term function in renal transplant recipients: two case reports.

Authors:  Rainer U Pliquett; Aida Asbe-Vollkopf; Ernst H Scheuermann; Elisabeth Gröne; Michael Probst; Helmut Geiger; Ingeborg A Hauser
Journal:  J Med Case Rep       Date:  2009-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.